coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    North Tandridge PCN, Tandridge · Health Inequalities Profile

    PCN U86169 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    27,894

    Registered population

    59.9% aged 18–64

    19.0%

    Aged 65+

    ICB 18.8% · England 17.9%

    17.6%

    Ethnic minority (non-White)

    6.3% Asian · England 9.6%

    0.4%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    ~137

    Core20 residents (est.)

    Resident basis; registered basis ~147 · see page 3

    5,527

    Hypertension register

    +5.78% in 3 yrs · England +5.60%

    305

    SMI register

    33.2% of Tandridge's

    566

    COPD register

    Reviews +0.28% in 3 yrs

    Forecast to 2030

    6,653

    Hypertension patients, 2030

    +1,126 on today

    75.2%

    QRISK ≥20% on statins, 2030

    +5.49pp over 3 yrs

    6.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    13
    13 three-year trends trail England's pace.

    SMI BMI checks fell 3.0 pp (England +5.1 pp) and BP checks fell 1.6 pp (England +4.4 pp), which may reflect unverified recall slippage.

    4.9 pp
    Age-five MMR coverage drops between doses.

    Age-five MMR1 reaches 95.0%, but MMR2 is 90.1% (6.4 pp lower at Warlingham Green Med Prac), which could reflect pre-school recall gaps.

    73.8%
    Current cardiovascular and respiratory checks exceed England.

    Hypertension treated to target is 73.8% (England 70.3%) and COPD annual reviews reach 83.9% (England 76.4%), showing strong current care-process delivery.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ reach 19.0% alongside practice list discrepancies across three member practices

    Registered patients aged 65+ represent 19.0% (5,311), below Tandridge (20.9%) but above NHS Surrey Heartlands Integrated Care Board (18.8%) and England (17.9%). Patients aged 0-17 account for 21.1% (5,877; Tandridge 20.4%, ICB 20.4%, England 19.6%). Census resident estimates (not registered patients) are 82.5% White (Tandridge 89.4%, ICB 85.3%, England 81.1%), 6.3% Asian, 5.3% Mixed and 4.6% Black. Practice lists total 38,613 versus the 27,894 PCN list, so denominators must be reconciled when planning capacity.

    Age profile

    0–1721.1%
    18–6459.9%
    65+19.0%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White82.5%
    Asian6.3%
    Mixed5.3%
    Black4.6%
    Other1.3%

    Older people · falls rows are Tandridge local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Tandridge LA)2,4552,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)81.0%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.4%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Tandridge LA)1,2339819552024/25
    Falls deaths, all ages, per 100,000 (Tandridge LA)12.014.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 0.4% overall and concentrated at Warlingham Green Med Prac

    The PCN records low overall deprivation, with an average IMD decile of 7.6 compared to 7.1 in Tandridge, 7.9 in the ICB and 5.5 in England. Only 0.4% of registered patients live in Core20 areas, below England (21.0%) and the ICB (0.8%; Tandridge 0.0%). Deprivation is concentrated at Warlingham Green Med Prac (0.7% share, 147 estimated patients), while Caterham Valley Medical Practice and Elizabeth House Medical Practice report 0.0%. Practice list sizes sum to 38,613 against the 27,894 PCN list. Targeted health inequality outreach can focus on the single practice.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Warlingham Green0.7% · 147 patients
    Caterham Valley0.0% · 0 patients
    Elizabeth House0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    305

    SMI register

    0.80% recorded prevalence

    200

    Learning disability register

    0.52% recorded prevalence

    22

    Care homes, 578 beds

    In the PCN catchment

    8.3%

    Provide unpaid care

    Tandridge, Census 2021

    Recorded learning disability prevalence is 0.5% (200 patients), below Tandridge (0.7%) and England (0.6%), and matching NHS Surrey Heartlands Integrated Care Board (0.5%). Severe mental illness prevalence is 0.8% (305 patients), matching Tandridge (0.8%) and the ICB (0.8%), but below England (1.0%). The PCN catchment contains 22 care homes with 578 beds.

    Severe mental illness: physical health checks

    SMI BP checks reach 87.0% (England 83.4%) and BMI 85.3% (England 82.1%). Over three years, BP checks fell 1.6 pp (England +4.4 pp) and BMI fell 3.0 pp (England +5.1 pp), consistent with unverified recall slippage an audit could test.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,527

    Hypertension register

    +5.78%

    Register growth, 3 yrs

    Tandridge +6.34% · England +5.60%

    −0.97pp

    BP control, under 80

    ≤140/90 · −1.08pp aged 80+

    +1,126

    More patients by 2030

    Forecast 6,653 (16.23%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 14.5% (5,527 patients), below England (15.2%) and Tandridge (15.3%), but above NHS Surrey Heartlands ICB (14.3%); the register implies a 38,117 base against the 27,894 list. While 73.8% of patients are treated to target (England 70.3%) and 90.5% have a recent blood pressure check (England 90.0%), control fell 1.4% over three years (England +3.6%) and checks fell 0.7% (England +3.6%). Under-80 control also fell 1.3% (England +3.2%). Slower three-year progress may reflect recall slippage (unverified locally). Slipping control trends behind England indicate that maintaining blood pressure recall protocols should be prioritised to prevent further erosion of current achievement.

    Lipids and statins

    Among patients with QRISK ≥ 20%, lipid-lowering therapy reaches 62.6% (England 63.6%, Tandridge 58.5%, ICB 59.4%) following +9.6% three-year growth (England +6.2%). Statin uptake in diabetes (40+ without CVD) is 75.3% (England 73.2%). Lower high-risk lipid coverage than England indicates untreated QRISK patients warrant review.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202646,849£2.40£2.24£1.86£112,438
    Cardiovascular (all), 202561,357£4.45£4.74£3.33£273,039

    In 2026, lipid-regulating drugs cost £2.40 per item across 46,849 items, above England (£1.86), Tandridge (£2.36) and the ICB (£2.24), representing £25,298 more than at England's unit cost. Unit costs may reflect formulary choices or case-mix rather than inefficiency. Higher unit costs warrant reviewing lipid-modifying formulary choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +7.35%

    Asthma reviews, PCN 3-yr change

    +4.44%

    Asthma reviews, England

    +6.03%

    Asthma prevalence, PCN

    COPD prevalence is 1.5% (566 patients), below England (1.9%) but rising +15.5% over three years (England +2.6%), with reviews reaching 83.9% (England 76.4%). Asthma prevalence is 6.2% (2,221 patients; England 6.6%), and reviews reached 70.3% (England 65.7%), leaving about 660 patients unreviewed. Second-hand smoking status was recorded for 88.0% of asthma patients aged 6-19 (England 78.8%). Implied denominator differences (a 37,987 base) urge caution, though proactive recall could address unreviewed patients.

    Cancer register and children's immunisation

    Cancer register prevalence is 4.7% (1,786 patients), above England (3.8%). In Q1 2025/26 childhood immunisations, 6-in-1 coverage at 12 months is 95.8%, meeting the 95.0% target. MMR dose 1 at 24 months is 88.6% (6.4 pp below target). At age 5, MMR dose 1 reaches 95.0%, but MMR dose 2 is 4.9 pp lower at 90.1% and 4-in-1 booster coverage is 88.1% (6.9 pp below target).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months95.8%

    England 91.0%

    6-in-1 complete primary course at 24 months92.4%

    England 92.2%

    MMR dose 1 at 24 months88.6%

    England 88.3%

    MMR dose 2 at age 590.1%

    England 82.8%

    4-in-1 pre-school booster at age 588.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    In 2022, 61.4% of cancers with a known stage (2,955 of 4,810) across NHS Surrey Heartlands ICB were diagnosed at stage 1 or 2 (England 55.3%), trailing the 75.0% national ambition, with about 650 extra early-stage cases needed. Staging was known for 67.7% of cancers (4,810 of 7,106; England 67.0%), reflecting system pathways rather than PCN care. Locally, breast screening coverage is 68.4% (England 69.9%, ICB 71.2%) and rose +4.5% over three years (England +8.4%), lowest at Warlingham Green Med Prac (65.9%). Slower screening progress may reflect recall variation (unverified locally; a practice audit could test it).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Surrey and Sussex Healthcare NHS Trust achieved 70.0% on the 62-day cancer standard (target 85.0%), below England (71.2%), NHS Surrey and Sussex Integrated Care Board (71.5%) and King's College Hospital NHS Foundation Trust (70.1%), but above Croydon Health Services NHS Trust (69.9%). The trust met the 28-day faster diagnosis standard at 77.7% (standard 75.0%). Diagnostic 6-week waits reached 28.5% across all tests (England 23.1%, King's College Hospital NHS Foundation Trust 19.1%, Croydon Health Services NHS Trust 3.5%), with ultrasound at 32.3% and echocardiography at 43.8%. These provider metrics describe system context, not PCN performance.

    Pathways within standard (%)Surrey and Sussex HealthcareCroydon HealthKing's CollegeSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)77.7483.2280.6879.2979.32
    31-day treatment (96%)96.2099.0696.6890.4592.50
    62-day referral to treatment (85%)69.9769.8870.1571.5171.16
    Diagnostic waits over 6 weeks (%)Surrey and Sussex HealthcareCroydon HealthKing's CollegeEngland
    MRI27.530.2621.2221.40
    CT18.497.6922.609.92
    Echocardiography43.783.6014.3928.48
    Colonoscopy15.1121.8041.8130.83
    Gastroscopy21.0617.9435.9829.02
    All 15 DM01 tests28.503.5119.1523.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In provisional June 2026 data, Surrey recorded 109,530 community care contacts across 33,510 patients (66,060 activities), with adults aged 65+ accounting for 69.6% of contacts. Across NHS Surrey and Sussex Integrated Care Board, community contacts totaled 309,615 (316,320 activities). These experimental figures reflect broad resident service volumes rather than unique North Tandridge PCN activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access varies by 16.6 pp while overall experience exceeds England

    In 2025/26, QOF clinical achievement reached 96.0% to 99.9% (England 97.1%). However, vaccination and immunisation achievement trailed England (55.2%), spanning 12.8 pp from Warlingham Green Med Prac (34.0%) to Caterham Valley Medical Practice (46.8%), while Elizabeth House Medical Practice recorded 36.1%. Overall personalised care adjustments were 4.6% to 7.2% (England 10.0%).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Warlingham Green970.768.5%76.5%93.2%
    Elizabeth House1240.079.4%74.5%90.6%
    Caterham Valley1060.062.8%70.6%82.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNTandridgeAssetPCNTandridge
    Care homes (catchment)22 (578 beds)n/aSchools (catchment)50n/a
    Children's centres36Places of worship3261
    Libraries24Food banks (VCS)22
    Day centres (VCS)n/a5Children and young people (VCS)n/a1
    Carers support groups (VCS)n/a3Primary schools (LA maintained)514
    Primary academies811Special schoolsn/a3

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    SMI and hypertension recall audit

    Thirteen of 25 measures trail England's 2023 to 2025 change: SMI BMI fell 3.0 pp (England +5.1 pp), SMI BP fell 1.6 pp (England +4.4 pp) and hypertension control fell 1.4% (England +3.6%). For discussion: audit SMI and hypertension recall lists, starting at Caterham Valley Medical Practice (80.8% SMI BP). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 2

    Pre-school MMR2 and booster catch-up

    At age 5 (Q1 2025/26, 101 children), MMR1 is 95.0% but MMR2 is 4.9 pp lower at 90.1% (6.4 pp difference at Warlingham Green Med Prac); 4-in-1 booster is 88.1% (below the 95.0% target by 6.9 pp). For discussion: run pre-school recall checks for second MMR and 4-in-1 booster doses. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 3

    Asthma review and lipid therapy

    Asthma reviews reach 70.3% of 2,221 patients (England 65.7%), leaving about 660 unreviewed; QRISK ≥ 20% lipid therapy is 62.6% (England 63.6%) and 2026 lipid-modifying unit cost is £2.40 (£25,298 more than England's £1.86 across 46,849 items). For discussion: recall unreviewed asthma patients and review QRISK lipid-modifying prescribing. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult list reconciliation (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Severe mental illness recall audit (p4)Record of BMI in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Hypertension patients with a recent blood pressure readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school immunisation catch-up outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted breast screening recall outreach (p7)Breast screening coverage: aged 53 to 70 years old—PCN
    Practice telephony and triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · SMI and hypertension recall audit (p12)SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs) · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to Hope · Core20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Pre-school MMR2 and booster catch-up (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 3 · Asthma review and lipid therapy (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with QRISK ≥ 20% treated with lipid lowering therapyCore20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15